NCT03699943 is a NA clinical trial of CaverStem in Erectile Dysfunction, sponsored by Creative Medical Health, Inc..

Who is sponsoring NCT03699943?

NCT03699943 is sponsored by Creative Medical Health, Inc..

What drugs are being tested in NCT03699943?

Interventions in NCT03699943: CaverStem.

What condition does NCT03699943 study?

NCT03699943 studies Erectile Dysfunction.

Is NCT03699943 still recruiting?

NCT03699943 is currently completed. Last updated 6 September 2019.

Last reviewed 2019-09-06 · How we verify

NCT03699943

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Autologous Bone Marrow Concentrate in Treatment of Erectile Dysfunction.

Completed NA Last updated 6 September 2019

What this trial tests

NA trial testing CaverStem in Erectile Dysfunction in 40 participants. Completed in 31 August 2019.

Timeline

8 December 2015

Primary endpoint
31 August 2018

31 August 2019

Quick facts

Lead sponsor	Creative Medical Health, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	sequential
Masking	single
Primary purpose	treatment
Enrollment	40
Start date	8 December 2015
Primary completion	31 August 2018
Estimated completion	31 August 2019
Sites	1 location across United States

Drugs / interventions tested

CaverStem

Conditions studied

Erectile Dysfunction — all drugs for Erectile Dysfunction →

Sponsor

Creative Medical Health, Inc.

Who can join

Adults 18 to 85, male only, with Erectile Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study assessed the safety and efficacy of autologous bone marrow concentrate and injected intra-cavernously into patients with erectile dysfunction (ED). Specifically, this study will evaluate ED treatment \>18 year old men, a demographic where the etiology of ED is attributable primarily to the loss of corporal smooth muscle in the penis. Study endpoints will evaluate the safety and efficacy of intracavernosal bone marrow concentrate administration for treating ED patients.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Phase I and registry study of autologous bone marrow concentrate evaluated in PDE5 inhibitor refractory erectile dysfunction.
Bieri M, Said E, Antonini G, Dickerson D, et al · · 2020 · cited 11× · PMID 31937310 · DOI 10.1186/s12967-019-02195-w
Autologous Immune Cell-Based Regenerative Therapies to Treat Vasculogenic Erectile Dysfunction: Is the Immuno-Centric Revolution Ready for the Prime Time?
Bonanni M, Rehak L, Massaro G, Benedetto D, et al · · 2022 · cited 7× · PMID 35625828 · DOI 10.3390/biomedicines10051091
Expert Consensus on Prevention and Treatment of Aging-Related Gonadal Dysfunction.
Wang X, Ma L, Jiang S, Wen J, et al · · 2024 · cited 2× · PMID 38739936 · DOI 10.14336/ad.2024.0004

Verify or expand the search:

Other recruiting trials for Erectile Dysfunction

Currently open trials in the same condition.

NCT07442396 — The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation · NA · recruiting
NCT07366970 — Is There a Benefit From Addition of Exercise in Diabetic Patients With ED Who Complain Low Vitamin D? · NA · recruiting
NCT06960746 — Changing Lifestyle in OSA Males Who Suffer Metabolic Syndrome and Impotence: Is There a Response? · NA · recruiting
NCT06872866 — The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under · Phase 1 · recruiting
NCT06805513 — Actual Use Trial of Tadalafil 5 mg · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03699943 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Creative Medical Health, Inc.
Last refreshed: 6 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03699943.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing